Global Neglected Tropical Diseases Market

Neglected Tropical Diseases Comprehensive Study by Therapy (Drugs, Vaccines, Bandages, Injections, Others), Disease (Buruli Ulcer, Chagas Disease, Cysticercosis, Dengue Fever, Others), Age (Adults, Children), Tests (General Check-up, Blood Tests, Urine Tests, Saliva Tests, Others) Players and Region - Global Market Outlook to 2030

Neglected Tropical Diseases Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Neglected Tropical Diseases
Neglected Tropical Diseases (NTDs) are a category of tropical infections that are prevalent in low-income communities in Africa, Asia, and the Americas. Viruses, bacteria, protozoa, and parasitic worms are among the pathogens that cause them. These diseases are compared with the major three infectious diseases (HIV/AIDS, tuberculosis, and malaria), which are treated and researched more extensively. The combined impact of these diseases in Sub-Saharan Africa is equivalent to malaria and tuberculosis. Neglected tropical diseases impact the poorest members of society in developing nations. The burdens of neglected tropical diseases are frequently overshadowed by other public health problems in countries like these. Many of the same questions, however, put populations of developed and emerging countries at risk. As the research and awareness about these diseases increase, the demand and capacity for their treatment are also increasing.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

F. Hoffmann-La Roche Ltd (Switzerland), Bayer AG (Germany), GSK (United Kingdom), Novartis AG (Switzerland), Pfizer, Inc. (United States), Eisai Co. Ltd. (Tokyo), Sanofi (France), Astellas Pharma (Japan), Takeda Pharmaceutical Company Limited (Japan) and Gilead Sciences (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Neglected Tropical Diseases market by and Region.



On the basis of geography, the market of Neglected Tropical Diseases has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Therapy, the sub-segment i.e. Drugs will boost the Neglected Tropical Diseases market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disease, the sub-segment i.e. Buruli Ulcer will boost the Neglected Tropical Diseases market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Age, the sub-segment i.e. Adults will boost the Neglected Tropical Diseases market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Tests, the sub-segment i.e. General Check-up will boost the Neglected Tropical Diseases market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Donations for The Treatment of Neglected Tropical Diseases and Growing Awareness About Economic Impact of Neglected Tropical Diseases

Market Growth Drivers:
Huge Amount of Population Which Needs Treatment of Neglected Tropical Diseases and WHO Campaigns And Funding Driving The Neglected Tropical Diseases Market

Challenges:
Drug and Treatment Delivery to Remote Areas Is Challenging and As Profit Is Less in The Treatment of Neglected Tropical Diseases There Is Lack of Efforts by Companies

Restraints:
The inability of Many Nations States to Pay Attention to Neglected Tropical Diseases

Opportunities:
Increasing Number of Policies to Curb Neglected Tropical Diseases and Growing Quality of Health Infrastructures in Nations Like China and India

On 5th April 2018, Takeda Pharmaceutical Co., Ltd. and the Drugs for Neglected Diseases initiative have announced a collaboration to perform preclinically and phase I clinical trials on drug candidate compounds found in the aminopyrazole compound class, with the aim of creating a novel drug for the treatment of visceral leishmaniasis. They will contribute to the advancement of therapies for Neglected Tropical Diseases through this program.
WHO has provided guidelines for the use of ferritin concentrates to access iron status in individuals and populations. These guidelines are regarding the use of Ferritin which is used to tackle iron deficiency in the population. According to guidelines- “Ferritin concentration is a good marker of iron stores and should be used to diagnose iron deficiency in otherwise apparently healthy individuals. In individuals with infection or inflammation, a ferritin concentration below 30 μg/L in children and 70 μg/L in adults may be used to indicate iron deficiency”

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Neglected Tropical Diseases Treatment Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations, End-Use Industries and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Therapy
  • Drugs
  • Vaccines
  • Bandages
  • Injections
  • Others

By Disease
  • Buruli Ulcer
  • Chagas Disease
  • Cysticercosis
  • Dengue Fever
  • Others

By Age
  • Adults
  • Children

By Tests
  • General Check-up
  • Blood Tests
  • Urine Tests
  • Saliva Tests
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Huge Amount of Population Which Needs Treatment of Neglected Tropical Diseases
      • 3.2.2. WHO Campaigns And Funding Driving The Neglected Tropical Diseases Market
    • 3.3. Market Challenges
      • 3.3.1. Drug and Treatment Delivery to Remote Areas Is Challenging
      • 3.3.2. As Profit Is Less in The Treatment of Neglected Tropical Diseases There Is Lack of Efforts by Companies
    • 3.4. Market Trends
      • 3.4.1. Increasing Donations for The Treatment of Neglected Tropical Diseases
      • 3.4.2. Growing Awareness About Economic Impact of Neglected Tropical Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neglected Tropical Diseases, by Therapy, Disease, Age, Tests and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Neglected Tropical Diseases (Value)
      • 5.2.1. Global Neglected Tropical Diseases by: Therapy (Value)
        • 5.2.1.1. Drugs
        • 5.2.1.2. Vaccines
        • 5.2.1.3. Bandages
        • 5.2.1.4. Injections
        • 5.2.1.5. Others
      • 5.2.2. Global Neglected Tropical Diseases by: Disease (Value)
        • 5.2.2.1. Buruli Ulcer
        • 5.2.2.2. Chagas Disease
        • 5.2.2.3. Cysticercosis
        • 5.2.2.4. Dengue Fever
        • 5.2.2.5. Others
      • 5.2.3. Global Neglected Tropical Diseases by: Age (Value)
        • 5.2.3.1. Adults
        • 5.2.3.2. Children
      • 5.2.4. Global Neglected Tropical Diseases by: Tests (Value)
        • 5.2.4.1. General Check-up
        • 5.2.4.2. Blood Tests
        • 5.2.4.3. Urine Tests
        • 5.2.4.4. Saliva Tests
        • 5.2.4.5. Others
      • 5.2.5. Global Neglected Tropical Diseases Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Neglected Tropical Diseases: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GSK (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Eisai Co. Ltd. (Tokyo)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Astellas Pharma (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Takeda Pharmaceutical Company Limited (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Gilead Sciences (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Neglected Tropical Diseases Sale, by Therapy, Disease, Age, Tests and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Neglected Tropical Diseases (Value)
      • 7.2.1. Global Neglected Tropical Diseases by: Therapy (Value)
        • 7.2.1.1. Drugs
        • 7.2.1.2. Vaccines
        • 7.2.1.3. Bandages
        • 7.2.1.4. Injections
        • 7.2.1.5. Others
      • 7.2.2. Global Neglected Tropical Diseases by: Disease (Value)
        • 7.2.2.1. Buruli Ulcer
        • 7.2.2.2. Chagas Disease
        • 7.2.2.3. Cysticercosis
        • 7.2.2.4. Dengue Fever
        • 7.2.2.5. Others
      • 7.2.3. Global Neglected Tropical Diseases by: Age (Value)
        • 7.2.3.1. Adults
        • 7.2.3.2. Children
      • 7.2.4. Global Neglected Tropical Diseases by: Tests (Value)
        • 7.2.4.1. General Check-up
        • 7.2.4.2. Blood Tests
        • 7.2.4.3. Urine Tests
        • 7.2.4.4. Saliva Tests
        • 7.2.4.5. Others
      • 7.2.5. Global Neglected Tropical Diseases Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neglected Tropical Diseases: by Therapy(USD Million)
  • Table 2. Neglected Tropical Diseases Drugs , by Region USD Million (2018-2023)
  • Table 3. Neglected Tropical Diseases Vaccines , by Region USD Million (2018-2023)
  • Table 4. Neglected Tropical Diseases Bandages , by Region USD Million (2018-2023)
  • Table 5. Neglected Tropical Diseases Injections , by Region USD Million (2018-2023)
  • Table 6. Neglected Tropical Diseases Others , by Region USD Million (2018-2023)
  • Table 7. Neglected Tropical Diseases: by Disease(USD Million)
  • Table 8. Neglected Tropical Diseases Buruli Ulcer , by Region USD Million (2018-2023)
  • Table 9. Neglected Tropical Diseases Chagas Disease , by Region USD Million (2018-2023)
  • Table 10. Neglected Tropical Diseases Cysticercosis , by Region USD Million (2018-2023)
  • Table 11. Neglected Tropical Diseases Dengue Fever , by Region USD Million (2018-2023)
  • Table 12. Neglected Tropical Diseases Others , by Region USD Million (2018-2023)
  • Table 13. Neglected Tropical Diseases: by Age(USD Million)
  • Table 14. Neglected Tropical Diseases Adults , by Region USD Million (2018-2023)
  • Table 15. Neglected Tropical Diseases Children , by Region USD Million (2018-2023)
  • Table 16. Neglected Tropical Diseases: by Tests(USD Million)
  • Table 17. Neglected Tropical Diseases General Check-up , by Region USD Million (2018-2023)
  • Table 18. Neglected Tropical Diseases Blood Tests , by Region USD Million (2018-2023)
  • Table 19. Neglected Tropical Diseases Urine Tests , by Region USD Million (2018-2023)
  • Table 20. Neglected Tropical Diseases Saliva Tests , by Region USD Million (2018-2023)
  • Table 21. Neglected Tropical Diseases Others , by Region USD Million (2018-2023)
  • Table 22. South America Neglected Tropical Diseases, by Country USD Million (2018-2023)
  • Table 23. South America Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 24. South America Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 25. South America Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 26. South America Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 27. Brazil Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 28. Brazil Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 29. Brazil Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 30. Brazil Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 31. Argentina Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 32. Argentina Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 33. Argentina Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 34. Argentina Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 35. Rest of South America Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 36. Rest of South America Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 37. Rest of South America Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 38. Rest of South America Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 39. Asia Pacific Neglected Tropical Diseases, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 41. Asia Pacific Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 42. Asia Pacific Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 43. Asia Pacific Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 44. China Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 45. China Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 46. China Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 47. China Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 48. Japan Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 49. Japan Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 50. Japan Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 51. Japan Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 52. India Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 53. India Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 54. India Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 55. India Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 56. South Korea Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 57. South Korea Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 58. South Korea Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 59. South Korea Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 60. Taiwan Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 61. Taiwan Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 62. Taiwan Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 63. Taiwan Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 64. Australia Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 65. Australia Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 66. Australia Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 67. Australia Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 72. Europe Neglected Tropical Diseases, by Country USD Million (2018-2023)
  • Table 73. Europe Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 74. Europe Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 75. Europe Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 76. Europe Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 77. Germany Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 78. Germany Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 79. Germany Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 80. Germany Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 81. France Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 82. France Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 83. France Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 84. France Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 85. Italy Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 86. Italy Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 87. Italy Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 88. Italy Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 89. United Kingdom Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 90. United Kingdom Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 91. United Kingdom Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 92. United Kingdom Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 93. Netherlands Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 94. Netherlands Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 95. Netherlands Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 96. Netherlands Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 97. Rest of Europe Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 98. Rest of Europe Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 99. Rest of Europe Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 100. Rest of Europe Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 101. MEA Neglected Tropical Diseases, by Country USD Million (2018-2023)
  • Table 102. MEA Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 103. MEA Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 104. MEA Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 105. MEA Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 106. Middle East Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 107. Middle East Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 108. Middle East Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 109. Middle East Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 110. Africa Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 111. Africa Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 112. Africa Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 113. Africa Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 114. North America Neglected Tropical Diseases, by Country USD Million (2018-2023)
  • Table 115. North America Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 116. North America Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 117. North America Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 118. North America Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 119. United States Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 120. United States Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 121. United States Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 122. United States Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 123. Canada Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 124. Canada Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 125. Canada Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 126. Canada Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 127. Mexico Neglected Tropical Diseases, by Therapy USD Million (2018-2023)
  • Table 128. Mexico Neglected Tropical Diseases, by Disease USD Million (2018-2023)
  • Table 129. Mexico Neglected Tropical Diseases, by Age USD Million (2018-2023)
  • Table 130. Mexico Neglected Tropical Diseases, by Tests USD Million (2018-2023)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Neglected Tropical Diseases: by Therapy(USD Million)
  • Table 142. Neglected Tropical Diseases Drugs , by Region USD Million (2025-2030)
  • Table 143. Neglected Tropical Diseases Vaccines , by Region USD Million (2025-2030)
  • Table 144. Neglected Tropical Diseases Bandages , by Region USD Million (2025-2030)
  • Table 145. Neglected Tropical Diseases Injections , by Region USD Million (2025-2030)
  • Table 146. Neglected Tropical Diseases Others , by Region USD Million (2025-2030)
  • Table 147. Neglected Tropical Diseases: by Disease(USD Million)
  • Table 148. Neglected Tropical Diseases Buruli Ulcer , by Region USD Million (2025-2030)
  • Table 149. Neglected Tropical Diseases Chagas Disease , by Region USD Million (2025-2030)
  • Table 150. Neglected Tropical Diseases Cysticercosis , by Region USD Million (2025-2030)
  • Table 151. Neglected Tropical Diseases Dengue Fever , by Region USD Million (2025-2030)
  • Table 152. Neglected Tropical Diseases Others , by Region USD Million (2025-2030)
  • Table 153. Neglected Tropical Diseases: by Age(USD Million)
  • Table 154. Neglected Tropical Diseases Adults , by Region USD Million (2025-2030)
  • Table 155. Neglected Tropical Diseases Children , by Region USD Million (2025-2030)
  • Table 156. Neglected Tropical Diseases: by Tests(USD Million)
  • Table 157. Neglected Tropical Diseases General Check-up , by Region USD Million (2025-2030)
  • Table 158. Neglected Tropical Diseases Blood Tests , by Region USD Million (2025-2030)
  • Table 159. Neglected Tropical Diseases Urine Tests , by Region USD Million (2025-2030)
  • Table 160. Neglected Tropical Diseases Saliva Tests , by Region USD Million (2025-2030)
  • Table 161. Neglected Tropical Diseases Others , by Region USD Million (2025-2030)
  • Table 162. South America Neglected Tropical Diseases, by Country USD Million (2025-2030)
  • Table 163. South America Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 164. South America Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 165. South America Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 166. South America Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 167. Brazil Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 168. Brazil Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 169. Brazil Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 170. Brazil Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 171. Argentina Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 172. Argentina Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 173. Argentina Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 174. Argentina Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 175. Rest of South America Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 176. Rest of South America Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 177. Rest of South America Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 178. Rest of South America Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 179. Asia Pacific Neglected Tropical Diseases, by Country USD Million (2025-2030)
  • Table 180. Asia Pacific Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 181. Asia Pacific Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 182. Asia Pacific Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 183. Asia Pacific Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 184. China Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 185. China Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 186. China Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 187. China Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 188. Japan Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 189. Japan Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 190. Japan Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 191. Japan Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 192. India Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 193. India Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 194. India Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 195. India Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 196. South Korea Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 197. South Korea Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 198. South Korea Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 199. South Korea Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 200. Taiwan Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 201. Taiwan Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 202. Taiwan Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 203. Taiwan Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 204. Australia Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 205. Australia Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 206. Australia Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 207. Australia Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 208. Rest of Asia-Pacific Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 209. Rest of Asia-Pacific Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 210. Rest of Asia-Pacific Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 211. Rest of Asia-Pacific Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 212. Europe Neglected Tropical Diseases, by Country USD Million (2025-2030)
  • Table 213. Europe Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 214. Europe Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 215. Europe Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 216. Europe Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 217. Germany Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 218. Germany Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 219. Germany Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 220. Germany Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 221. France Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 222. France Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 223. France Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 224. France Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 225. Italy Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 226. Italy Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 227. Italy Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 228. Italy Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 229. United Kingdom Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 230. United Kingdom Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 231. United Kingdom Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 232. United Kingdom Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 233. Netherlands Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 234. Netherlands Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 235. Netherlands Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 236. Netherlands Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 237. Rest of Europe Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 238. Rest of Europe Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 239. Rest of Europe Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 240. Rest of Europe Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 241. MEA Neglected Tropical Diseases, by Country USD Million (2025-2030)
  • Table 242. MEA Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 243. MEA Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 244. MEA Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 245. MEA Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 246. Middle East Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 247. Middle East Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 248. Middle East Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 249. Middle East Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 250. Africa Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 251. Africa Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 252. Africa Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 253. Africa Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 254. North America Neglected Tropical Diseases, by Country USD Million (2025-2030)
  • Table 255. North America Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 256. North America Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 257. North America Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 258. North America Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 259. United States Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 260. United States Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 261. United States Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 262. United States Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 263. Canada Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 264. Canada Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 265. Canada Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 266. Canada Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 267. Mexico Neglected Tropical Diseases, by Therapy USD Million (2025-2030)
  • Table 268. Mexico Neglected Tropical Diseases, by Disease USD Million (2025-2030)
  • Table 269. Mexico Neglected Tropical Diseases, by Age USD Million (2025-2030)
  • Table 270. Mexico Neglected Tropical Diseases, by Tests USD Million (2025-2030)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neglected Tropical Diseases: by Therapy USD Million (2018-2023)
  • Figure 5. Global Neglected Tropical Diseases: by Disease USD Million (2018-2023)
  • Figure 6. Global Neglected Tropical Diseases: by Age USD Million (2018-2023)
  • Figure 7. Global Neglected Tropical Diseases: by Tests USD Million (2018-2023)
  • Figure 8. South America Neglected Tropical Diseases Share (%), by Country
  • Figure 9. Asia Pacific Neglected Tropical Diseases Share (%), by Country
  • Figure 10. Europe Neglected Tropical Diseases Share (%), by Country
  • Figure 11. MEA Neglected Tropical Diseases Share (%), by Country
  • Figure 12. North America Neglected Tropical Diseases Share (%), by Country
  • Figure 13. Global Neglected Tropical Diseases share by Players 2023 (%)
  • Figure 14. Global Neglected Tropical Diseases share by Players (Top 3) 2023(%)
  • Figure 15. Global Neglected Tropical Diseases share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2023
  • Figure 19. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 21. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. GSK (United Kingdom) Revenue: by Geography 2023
  • Figure 23. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 25. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Eisai Co. Ltd. (Tokyo) Revenue, Net Income and Gross profit
  • Figure 28. Eisai Co. Ltd. (Tokyo) Revenue: by Geography 2023
  • Figure 29. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 30. Sanofi (France) Revenue: by Geography 2023
  • Figure 31. Astellas Pharma (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Astellas Pharma (Japan) Revenue: by Geography 2023
  • Figure 33. Takeda Pharmaceutical Company Limited (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Takeda Pharmaceutical Company Limited (Japan) Revenue: by Geography 2023
  • Figure 35. Gilead Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 36. Gilead Sciences (United States) Revenue: by Geography 2023
  • Figure 37. Global Neglected Tropical Diseases: by Therapy USD Million (2025-2030)
  • Figure 38. Global Neglected Tropical Diseases: by Disease USD Million (2025-2030)
  • Figure 39. Global Neglected Tropical Diseases: by Age USD Million (2025-2030)
  • Figure 40. Global Neglected Tropical Diseases: by Tests USD Million (2025-2030)
  • Figure 41. South America Neglected Tropical Diseases Share (%), by Country
  • Figure 42. Asia Pacific Neglected Tropical Diseases Share (%), by Country
  • Figure 43. Europe Neglected Tropical Diseases Share (%), by Country
  • Figure 44. MEA Neglected Tropical Diseases Share (%), by Country
  • Figure 45. North America Neglected Tropical Diseases Share (%), by Country
List of companies from research coverage that are profiled in the study
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bayer AG (Germany)
  • GSK (United Kingdom)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (United States)
  • Eisai Co. Ltd. (Tokyo)
  • Sanofi (France)
  • Astellas Pharma (Japan)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Gilead Sciences (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 214 Pages 85 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Neglected Tropical Diseases Market Quantitative research analysis
Global Neglected Tropical Diseases Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as F. Hoffmann-La Roche Ltd (Switzerland), Bayer AG (Germany), GSK (United Kingdom), Novartis AG (Switzerland), Pfizer, Inc. (United States), Eisai Co. Ltd. (Tokyo), Sanofi (France), Astellas Pharma (Japan), Takeda Pharmaceutical Company Limited (Japan) and Gilead Sciences (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Donations for The Treatment of Neglected Tropical Diseases " is seen as one of major influencing trends for Neglected Tropical Diseases Market during projected period 2023-2030.
The Neglected Tropical Diseases market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Neglected Tropical Diseases Market Report?

Have a Query? Click Here

Other Related Reports

Idiopathic Hypersomnia Treatment  Comprehensive Study by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), Treatment Type (Prescription Medications (Stimulant Medications, Sodium...
$ 3650
Fluorescein Angiography Comprehensive Study by Type (Device, Disposables, Accessories), End-users (Hospitals, Ambulatory Surgical Centres, Others), Technology (Digital, Analog) Players and Region - G...
$ 3500
Lymphoedema Diagnostics Comprehensive Study by Type (Surgery, Compression, Others), Application (Hospitals, Diagnostic Centres, Research and Academic Centres, Others), Disease Type (Cardiovascular Di...
$ 3750
Pancreatic And Bile Duct Stone Management Comprehensive Study by Type (ERCP Catheters, Guidewires, Sphincterotomes, Dilation Balloon Catheters, Extraction Balloon Catheters, Extraction Basket Cathete...
$ 3750
Iodine Contrast Media Comprehensive Study by Application (Hospitals, Specialty Clinics), Administration (Oral, Injectable, Rectal, Ureteral), Technology (X-Ray, Computed Tomography, Magnetic Resonanc...
$ 3650
Upper Limb Prosthetics Comprehensive Study by Type (Passive Prosthetic Devices, Body Powered Prosthetic Devices, Myoelectric Prosthetic Devices, Hybrid Prosthetic Devices), End Use (Hospitals, Prosth...
$ 3750